Research programme: restenosis therapies - NitroMed

Latest Information Update: 22 Aug 2007

Price : $50 ^*

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

31 Dec 2005 NitroMed and Boston Scientific have completed their collaboration on nitric oxide coated stents
31 Dec 2003 Nitromed and Boston Scientific have extended an agreement to co-promote and co-develop nitric oxide coated stents worldwide
30 Nov 2001 Preclinical trials in Coronary artery restenosis in USA (Implant)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com